Delivery Order SPE2DB22D2007-SPE2DB25FJ4SV
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,296.73 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Multaq 400 mg tablets (60 count). This firm fixed-price, non-set-aside contract is scheduled for completion by September 9, 2025, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, representing a critical pharmaceutical supply for military and...
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,234.92 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-unit package). This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the management of atrial fibrillation, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $5,881.89 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of cardiac arrhythmias, reflecting the pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,947.74 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, supporting the military...
- The Defense Logistics Agency awarded a delivery order valued at $10,061.44 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Multaq is a cardiovascular medication used in the treatment of atrial fibrillation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $8,201.13. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Multaq 400 mg tablets (60-count packages) valued at $92,596.99. This firm fixed-price delivery order represents a competitive award with no set-aside designation and has an ultimate completion date of August 27, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,985.90. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...